Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan C Frias

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|March 26, 2014
Molecule 16673-34-0: a new tool in our arsenal against inflammationMichael J Lipinski, Juan C Frias
Chemical Communications (Cambridge, England)|July 19, 2002
Highly emissive, nine-coordinate enantiopure lanthanide complexes incorporating tetraazatriphenylenes as probes for DNAGabriella Bobba, Juan C Frias, David Parker
Chemical Society Reviews|February 15, 2014
Visualizing the atherosclerotic plaque: a chemical perspectiveMa Teresa Albelda, Enrique Garcia-España, Juan C Frias
Contrast Media & Molecular Imaging|February 24, 2007
Modified lipoproteins as contrast agents for imaging of atherosclerosisJuan C Frias, Michael J Lipinski, Shawn E Lipinski, et al.
Journal of the American Chemical Society|December 17, 2004
Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaquesJuan C Frias, Kevin Jon Williams, Edward A Fisher, et al.
Organic & Biomolecular Chemistry|March 10, 2004
Studies on the interaction of phosphate anions with N-functionalised polyaza[n]paracyclophanes: the role of N-methylationM Teresa Albelda, Juan C Frias, Enrique García-España, et al.
Organic & Biomolecular Chemistry|August 22, 2003
Luminescent nonacoordinate cationic lanthanide complexes as potential cellular imaging and reactive probesJuan C Frias, Gabriella Bobba, Martin J Cann, et al.
Nano Letters|October 13, 2006
Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imagingJuan C Frias, Yanqing Ma, Kevin Jon Williams, et al.
Plos One|January 17, 2018
Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in miceIsabel Pont, Aracely Calatayud-Pascual, Alicia López-Castellano, et al.
Clinical Lipidology|March 31, 2010
HDL as a contrast agent for medical imagingDavid P Cormode, Juan C Frias, Yanqing Ma, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|March 26, 2014
Molecule 16673-34-0: a new tool in our arsenal against inflammationMichael J Lipinski, Juan C Frias
Chemical Communications (Cambridge, England)|July 19, 2002
Highly emissive, nine-coordinate enantiopure lanthanide complexes incorporating tetraazatriphenylenes as probes for DNAGabriella Bobba, Juan C Frias, David Parker
Chemical Society Reviews|February 15, 2014
Visualizing the atherosclerotic plaque: a chemical perspectiveMa Teresa Albelda, Enrique Garcia-España, Juan C Frias
Contrast Media & Molecular Imaging|February 24, 2007
Modified lipoproteins as contrast agents for imaging of atherosclerosisJuan C Frias, Michael J Lipinski, Shawn E Lipinski, et al.
Journal of the American Chemical Society|December 17, 2004
Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaquesJuan C Frias, Kevin Jon Williams, Edward A Fisher, et al.
Organic & Biomolecular Chemistry|March 10, 2004
Studies on the interaction of phosphate anions with N-functionalised polyaza[n]paracyclophanes: the role of N-methylationM Teresa Albelda, Juan C Frias, Enrique García-España, et al.
Organic & Biomolecular Chemistry|August 22, 2003
Luminescent nonacoordinate cationic lanthanide complexes as potential cellular imaging and reactive probesJuan C Frias, Gabriella Bobba, Martin J Cann, et al.
Nano Letters|October 13, 2006
Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imagingJuan C Frias, Yanqing Ma, Kevin Jon Williams, et al.
Plos One|January 17, 2018
Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in miceIsabel Pont, Aracely Calatayud-Pascual, Alicia López-Castellano, et al.
Clinical Lipidology|March 31, 2010
HDL as a contrast agent for medical imagingDavid P Cormode, Juan C Frias, Yanqing Ma, et al.
Pageof 2